- Online only
100CFU® Mycoplasma Standards are inactivated, non-infectious, lyophilized mycoplasma particles designed for use as an external positive control (EPC/EIC) in PCR-based mycoplasma testing.
- Compliant with EP 2.6.7 (12.2), USP <77>, and JP 18 G3
- Defined concentration of ≤100 CFU/ml, GC:CFU ratio <10
- Recommended for use as EPC/EIC
Cat. no.: 106-9001
Validation Guide for 100CFU® Spiroplasma citri
Please use this form to request a validation guide.
All fields are required. Please use your business contact data.
Please provide your first name. Please provide your last name. The e-mail seems to be missing or incorrect. Please provide your company/institution. Send Validation GuideMycoplasma contamination represents one of the major risks in cell culture systems and biopharmaceutical manufacturing, including ATMPs. The European Pharmacopoeia (EP) 2.6.7, the United States Pharmacopeia (USP) <77>, and the Japanese Pharmacopoeia (JP) 18 G3 require validated test methods capable of reliably detecting both cultivable and non-cultivable mycoplasma.
100CFU® Mycoplasma Standards were specifically developed to meet these regulatory requirements and are particularly intended for use as an External Positive Control (EPC). Manufactured in accordance with EP 2.6.7 (edition 12.2), the standards are non-infectious and safe to handle. After reconstitution, defined quantities of the standard are spiked into the respective product or sample matrix to enable robust assessment of assay performance under routine conditions and to support Limit of Detection (LOD) determination.
Spiroplasma citri belongs to the genus Spiroplasma and is phylogenetically distinct from classical mycoplasma species. It is particularly relevant for manufacturing processes involving insect or plant cell lines. The 100CFU® Spiroplasma citri standard supports matrix-specific assessment of potential contamination risks in non-mammalian expression systems.
| Product category | 100CFU® Mycoplasma Standards |
|---|---|
| Species | Spiroplasma citri |
| Sample type | Inactivated mycoplasma particles (DNA/RNA-containing) |
| NCTC code | 10164 |
| ATCC code | 27556 |
| Application | NAT-based mycoplasma testing |
| Application areas | External positiv control (EPC) or Extraction inhibition control (EIC) |
| Regulatory compliance | EP 2.6.7 (12.2), USP <77>, JP 18 G3 |
| Contents |
|
| Detection method |
|
| Required equipment & consumables |
|
| Concentration | ≤100 CFU/ml |
| Storage | 2-8 °C |
| Shipping | Ambient temperature |
| Shelf life | See package labeling |
Cat. No. 106-1001: Mycoplasma arginini
Cat. No. 106-2001: Mycoplasma orale
Cat. No. 106-3001: Mycoplasma gallisepticum
Cat. No. 106-4001: Mycoplasma pneumoniae
Cat. No. 106-5001: Mycoplasma synoviae
Cat. No. 106-6001: Mycoplasma fermentans
Cat. No. 106-7001: Mycoplasma hyorhinis
Cat. No. 106-8001: Acholeplasma laidlawii
Cat. No. 106-1101: Mycoplasma salivarium